Logo image of HSHP.OL

HIMALAYA SHIPPING LTD (HSHP.OL) Stock Fundamental Analysis

Europe - OSL:HSHP - BMG4660A1036 - Common Stock

80.9 NOK
-1.2 (-1.46%)
Last: 10/21/2025, 4:15:47 PM
Fundamental Rating

2

Overall HSHP gets a fundamental rating of 2 out of 10. We evaluated HSHP against 18 industry peers in the Marine Transportation industry. HSHP may be in some trouble as it scores bad on both profitability and health. HSHP is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HSHP was profitable.
In the past year HSHP had a positive cash flow from operations.
HSHP.OL Yearly Net Income VS EBIT VS OCF VS FCFHSHP.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

With a Return On Assets value of 0.74%, HSHP is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 4.03%, HSHP is doing worse than 88.89% of the companies in the same industry.
HSHP has a worse Return On Invested Capital (5.32%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA 0.74%
ROE 4.03%
ROIC 5.32%
ROA(3y)0.51%
ROA(5y)N/A
ROE(3y)4.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HSHP.OL Yearly ROA, ROE, ROICHSHP.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10

1.3 Margins

HSHP's Profit Margin of 5.32% is on the low side compared to the rest of the industry. HSHP is outperformed by 77.78% of its industry peers.
Looking at the Operating Margin, with a value of 47.90%, HSHP belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
With an excellent Gross Margin value of 76.12%, HSHP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
OM 47.9%
PM (TTM) 5.32%
GM 76.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HSHP.OL Yearly Profit, Operating, Gross MarginsHSHP.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HSHP is destroying value.
HSHP has about the same amout of shares outstanding than it did 1 year ago.
HSHP has a worse debt/assets ratio than last year.
HSHP.OL Yearly Shares OutstandingHSHP.OL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
HSHP.OL Yearly Total Debt VS Total AssetsHSHP.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that HSHP is in the distress zone and has some risk of bankruptcy.
HSHP's Altman-Z score of 0.81 is on the low side compared to the rest of the industry. HSHP is outperformed by 72.22% of its industry peers.
The Debt to FCF ratio of HSHP is 19.60, which is on the high side as it means it would take HSHP, 19.60 years of fcf income to pay off all of its debts.
HSHP has a Debt to FCF ratio of 19.60. This is in the lower half of the industry: HSHP underperforms 72.22% of its industry peers.
HSHP has a Debt/Equity ratio of 4.25. This is a high value indicating a heavy dependency on external financing.
HSHP has a Debt to Equity ratio of 4.25. This is amonst the worse of the industry: HSHP underperforms 94.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF 19.6
Altman-Z 0.81
ROIC/WACC0.65
WACC8.23%
HSHP.OL Yearly LT Debt VS Equity VS FCFHSHP.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

A Current Ratio of 0.95 indicates that HSHP may have some problems paying its short term obligations.
The Current ratio of HSHP (0.95) is worse than 66.67% of its industry peers.
HSHP has a Quick Ratio of 0.95. This is a bad value and indicates that HSHP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HSHP (0.90) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.9
HSHP.OL Yearly Current Assets VS Current LiabilitesHSHP.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The earnings per share for HSHP have decreased strongly by -50.00% in the last year.
The Revenue has grown by 44.78% in the past year. This is a very strong growth!
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
Revenue 1Y (TTM)44.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.17%

3.2 Future

The Earnings Per Share is expected to grow by 47.98% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.51% on average over the next years. This is quite good.
EPS Next Y2.71%
EPS Next 2Y60.79%
EPS Next 3Y47.98%
EPS Next 5YN/A
Revenue Next Year5.11%
Revenue Next 2Y17.52%
Revenue Next 3Y14.51%
Revenue Next 5YN/A

3.3 Evolution

HSHP.OL Yearly Revenue VS EstimatesHSHP.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M
HSHP.OL Yearly EPS VS EstimatesHSHP.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 57.38, the valuation of HSHP can be described as expensive.
88.89% of the companies in the same industry are cheaper than HSHP, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.69. HSHP is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 6.47 indicates a rather cheap valuation of HSHP.
HSHP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HSHP is cheaper than 61.11% of the companies in the same industry.
HSHP is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 57.38
Fwd PE 6.47
HSHP.OL Price Earnings VS Forward Price EarningsHSHP.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HSHP indicates a rather expensive valuation: HSHP more expensive than 83.33% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, HSHP is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.45
EV/EBITDA 12.14
HSHP.OL Per share dataHSHP.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HSHP's earnings are expected to grow with 47.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)21.19
PEG (5Y)N/A
EPS Next 2Y60.79%
EPS Next 3Y47.98%

0

5. Dividend

5.1 Amount

No dividends for HSHP!.
Industry RankSector Rank
Dividend Yield N/A

HIMALAYA SHIPPING LTD

OSL:HSHP (10/21/2025, 4:15:47 PM)

80.9

-1.2 (-1.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners25.24%
Inst Owner ChangeN/A
Ins Owners4.36%
Ins Owner ChangeN/A
Market Cap3.77B
Analysts81.67
Price Target87.21 (7.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.72
Dividend Growth(5Y)N/A
DP310.27%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.02%
Min EPS beat(2)-84.52%
Max EPS beat(2)26.47%
EPS beat(4)1
Avg EPS beat(4)-39.42%
Min EPS beat(4)-84.52%
Max EPS beat(4)26.47%
EPS beat(8)1
Avg EPS beat(8)-54.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-10.65%
Max Revenue beat(2)9.35%
Revenue beat(4)1
Avg Revenue beat(4)-2.54%
Min Revenue beat(4)-10.65%
Max Revenue beat(4)9.35%
Revenue beat(8)2
Avg Revenue beat(8)-3.09%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)13.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-14.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.66%
Revenue NY rev (1m)1.64%
Revenue NY rev (3m)-1.56%
Valuation
Industry RankSector Rank
PE 57.38
Fwd PE 6.47
P/S 3.1
P/FCF 10.45
P/OCF 10.49
P/B 2.35
P/tB 2.35
EV/EBITDA 12.14
EPS(TTM)1.41
EY1.74%
EPS(NY)12.5
Fwd EY15.45%
FCF(TTM)7.75
FCFY9.57%
OCF(TTM)7.71
OCFY9.53%
SpS26.12
BVpS34.48
TBVpS34.48
PEG (NY)21.19
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.74%
ROE 4.03%
ROCE 6.91%
ROIC 5.32%
ROICexc 5.48%
ROICexgc 5.48%
OM 47.9%
PM (TTM) 5.32%
GM 76.12%
FCFM 29.66%
ROA(3y)0.51%
ROA(5y)N/A
ROE(3y)4.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF 19.6
Debt/EBITDA 7.79
Cap/Depr 0.57%
Cap/Sales 0.14%
Interest Coverage 1.13
Cash Conversion 40.96%
Profit Quality 557.88%
Current Ratio 0.95
Quick Ratio 0.9
Altman-Z 0.81
F-Score7
WACC8.23%
ROIC/WACC0.65
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
EPS Next Y2.71%
EPS Next 2Y60.79%
EPS Next 3Y47.98%
EPS Next 5YN/A
Revenue 1Y (TTM)44.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.17%
Revenue Next Year5.11%
Revenue Next 2Y17.52%
Revenue Next 3Y14.51%
Revenue Next 5YN/A
EBIT growth 1Y38.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.7%
EBIT Next 3Y27.21%
EBIT Next 5YN/A
FCF growth 1Y110.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1062.73%
OCF growth 3YN/A
OCF growth 5YN/A